Catherine Chanfreau-Coffinier

3 weeks ago | ascpt.onlinelibrary.wiley.com | Catherine Chanfreau-Coffinier |Kevin A Friede |Mary E. Plomondon |Kyung Lee

WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Patients carrying CYP2C19 loss-of-function alleles have been shown to have an increased risk of major adverse cardiac events (MACE) following percutaneous coronary intervention for the indication of acute coronary syndrome (ACS). WHAT QUESTION DID THIS STUDY ADDRESS?